Evidence map›Paper›PMID 35801309›Full record

ArticleEMBO reports2022

IL-21 has a critical role in establishing germinal centers by amplifying early B cell proliferation.

Alexandra R Dvorscek, Craig I McKenzie, Marcus J Robinson, Zhoujie Ding, Catherine Pitt, Kristy O'Donnell, Dimitra Zotos, Robert Brink, David M Tarlinton, Isaak Quast

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Nanoparticle Immunoadjuvant Complexes Augment Germinal Center Responses to Vaccination.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. CD4Vaccines · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Alexandra R DvorscekDepartment of Immunology and Pathology, Monash University, Melbourne, Vic, Australia.ORCID 0000-0002-8617-2422
Craig I McKenzieDepartment of Immunology and Pathology, Monash University, Melbourne, Vic, Australia.
Marcus J RobinsonDepartment of Immunology and Pathology, Monash University, Melbourne, Vic, Australia.
Zhoujie DingDepartment of Immunology and Pathology, Monash University, Melbourne, Vic, Australia.
Catherine PittDepartment of Immunology and Pathology, Monash University, Melbourne, Vic, Australia.
Kristy O'DonnellDepartment of Immunology and Pathology, Monash University, Melbourne, Vic, Australia.ORCID 0000-0003-1964-4685
Dimitra ZotosDepartment of Immunology and Pathology, Monash University, Melbourne, Vic, Australia.
Robert BrinkImmunology Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
David M TarlintonDepartment of Immunology and Pathology, Monash University, Melbourne, Vic, Australia.ORCID 0000-0001-9928-686X
Isaak QuastDepartment of Immunology and Pathology, Monash University, Melbourne, Vic, Australia.ORCID 0000-0001-6517-8537
Monash University · AUGarvan Institute of Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proliferation and differentiation of antigen-specific B cells, including the generation of germinal centers (GC), are prerequisites for long-lasting, antibody-mediated immune protection. Affinity for antigen determines B cell recruitment, proliferation, differentiation, and competitiveness in the response, largely through determining access to T cell help. However, how T cell-derived signals contribute to these outcomes is incompletely understood. Here, we report how the signature cytokine of follicular helper T cells, IL-21, acts as a key regulator of the initial B cell response by accelerating cell cycle progression and the rate of cycle entry, increasing their contribution to the ensuing GC. This effect occurs over a wide range of initial B cell receptor affinities and correlates with elevated AKT and S6 phosphorylation. Moreover, the resultant increased proliferation can explain the IL-21-mediated promotion of plasma cell differentiation. Collectively, our data establish that IL-21 acts from the outset of a T cell-dependent immune response to increase cell cycle progression and fuel cyclic re-entry of B cells, thereby regulating the initial GC size and early plasma cell output.

Indexed as

Germinal CenterT-Lymphocytes, Helper-InducerAntigensCell DifferentiationCell ProliferationInterleukin-21InterleukinsAntigensInterleukin-21InterleukinsB cellscell cyclegerminal centerIL-21plasma cells

Identifiers

PMID35801309
PMCPMC9442303
OpenAlexW4284879889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.